Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
URGN
URGN
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
URGN News
Superstring Capital Reduces Stake in UroGen Pharma
6d ago
Fool
Superstring Capital Reduces Stake in UroGen Pharma
6d ago
NASDAQ.COM
Healthcare Stocks Rise 0.8% on NYSE Healthcare Index
May 13 2026
Yahoo Finance
Urogen Pharma CMO Mark Schoenberg Sells Shares
May 11 2026
Yahoo Finance
UroGen Pharma Reports Strong Q1 2026 Earnings with Significant ZUSDURI Growth
May 06 2026
seekingalpha
UroGen Pharma Q1 Earnings Beat Expectations
May 06 2026
seekingalpha
UroGen Pharma to Announce Q1 Earnings on May 6
May 05 2026
seekingalpha
UroGen Pharma Reports 2025 Financial Highlights
Mar 03 2026
NASDAQ.COM
UroGen Pharma Q4 2025 Earnings Call Highlights
Mar 02 2026
seekingalpha
UroGen (URGN) Q4 2025 Earnings Call Transcript
Mar 02 2026
NASDAQ.COM
UroGen Pharma Q4 Earnings Miss Expectations
Mar 02 2026
seekingalpha
UroGen's ZUSDURI Shows Efficacy at ASCO-GU 2026
Feb 27 2026
Newsfilter
Wildcat Capital Exits UroGen Pharma Position, Liquidating Approximately $6.79 Million
Dec 26 2025
Fool
Significant Options Trading on Wednesday: UTHR, URGN, DSGN
Dec 17 2025
NASDAQ.COM
D. Boral Capital Continues to Recommend Buying UroGen Pharma (URGN)
Oct 04 2025
NASDAQ.COM
Summit Takes Neutral Stance on Risk/Reward Dynamics as Piper Launches Coverage on Biotech Cancer Stocks
Aug 19 2025
SeekingAlpha
Show More News
